EMA updates Timelines of eAFs for Variations for Medicinal Products for Human Use

Recommendation
Wednesday, 21 May 2025 10.00 - 16.00 h
How to use and prepare an MA with a CEP 2.0
In future, submissions of variation notifications for medicinal products for human use are to be made exclusively via the electronic application forms (eAFs). The timelines for the full implementation of these systems have now been updated again and are listed on the EMA website in the PLM Portal (Product Lifecycle Management Portal).
Under the heading "What's New in PLM?" the newly defined timelines are shown and illustrated in the two-page document made available there. The mandatory use of electronic application forms is set for the end of the third quarter or the beginning of the fourth quarter of 2024 after a six-month transition period.
Please see the EMA website for the updated timelines and further information on the implementation of the electronic submission of variation notifications.
Related GMP News
16.04.2025EMA: Revised IRIS Documents
09.04.2025Centralised Procedures: Q&As Updated
12.03.2025CMDh/HMA: Guidance Documents on Variation Notifications Updated
11.03.2025EMA: Renewal of Q&A Document for "Centralized Procedures"
11.03.2025Centralised Procedures: Q&A Documents also Updated for Biosimilars
29.01.2025CMDh/HMA: Updated Guidance Documents on Variation Notifications